Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3856 AL 3870

Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms

Loi SM, Eratne D, Kelso W, Velakoulis D, Looi JC.

Australas Psychiatry. 2018 Aug;26(4):358-365. doi: 10.1177/1039856218766123. Epub 2018 Apr 19.

Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy

Cordero JG, García-Escudero R, Avila J, Gargini R, García-Escudero V.

Oxid Med Cell Longev. 2018 Feb 20;2018:5010741. doi: 10.1155/2018/5010741. eCollection 2018.

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

Goldman DP, Fillit H, Neumann P.

Alzheimers Dement. 2018 Jun;14(6):833-836. doi: 10.1016/j.jalz.2018.02.007. Epub 2018 Apr 18.

Cold Atmospheric Plasmas: A Novel and Promising Way to Treat Neurological Diseases

Xiong Z.

Trends Biotechnol. 2018 Jun;36(6):582-583. doi: 10.1016/j.tibtech.2018.04.003. Epub 2018 Apr 21.

ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease

Cummings JL, Cohen S, van Dyck CH, Brody M, Curtis C, Cho W, Ward M, Friesenhahn M, Rabe C, Brunstein F, Quartino A, Honigberg LA, Fuji RN, Clayton D, Mortensen D, Ho C, Paul R.

Neurology. 2018 May 22;90(21):e1889-e1897. doi: 10.1212/WNL.0000000000005550. Epub 2018 Apr 25.

Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions

Lee JH, Jahrling JB, Denner L, Dineley KT.

J Alzheimers Dis. 2018;64(s1):S427-S453. doi: 10.3233/JAD-179923.

Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study

Hong YJ, Choi SH, Jeong JH, Park KW, Na HR.

J Alzheimers Dis. 2018;63(3):1035-1044. doi: 10.3233/JAD-180159.

Exercise Intervention Associated with Cognitive Improvement in Alzheimer's Disease

Cui MY, Lin Y, Sheng JY, Zhang X, Cui RJ.

Neural Plast. 2018 Mar 11;2018:9234105. doi: 10.1155/2018/9234105. eCollection 2018.

A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

Ridha BH, Crutch S, Cutler D, Frost C, Knight W, Barker S, Epie N, Warrington EK, Kukkastenvehmas R, Douglas J, Rossor MN.

Alzheimers Res Ther. 2018 May 1;10(1):44. doi: 10.1186/s13195-018-0363-1.

Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials

Tsoi KK, Chan JY, Chan FC, Hirai HW, Kwok TC, Wong SY.

Clin Pharmacol Ther. 2019 Jan;105(1):121-130. doi: 10.1002/cpt.1104. Epub 2018 Jun 19.

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease

Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D.

N Engl J Med. 2018 May 3;378(18):1691-1703. doi: 10.1056/NEJMoa1706441.

Drug development for Alzheimer's disease: review

Lao K, Ji N, Zhang X, Qiao W, Tang Z, Gou X.

J Drug Target. 2019 Feb;27(2):164-173. doi: 10.1080/1061186X.2018.1474361. Epub 2018 Jun 20.

Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement

Wattmo C, Londos E, Minthon L.

Curr Alzheimer Res. 2018;15(10):905-916. doi: 10.2174/1567205015666180507105326.

Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region

Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Ajazuddin, Alexander A.

Expert Opin Drug Deliv. 2018 Jun;15(6):589-617. doi: 10.1080/17425247.2018.1471058. Epub 2018 May 17.

Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease

Goyal D, Kaur A, Goyal B.

ChemMedChem. 2018 Jul 6;13(13):1275-1299. doi: 10.1002/cmdc.201800156. Epub 2018 Jun 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias